Literature DB >> 31061594

Comparison of patellar tendon versus hamstrings autografts for anterior cruciate ligament reconstruction in Indian population: A randomised control trial study.

Prateek Ku Gupta1, Ashis Acharya1, Amit Mourya1, Prashant Mahajan2.   

Abstract

Disruption of anterior cruciate ligament (ACL) is a common ligamentous injury of the knee. The best choice of graft for reconstruction remains undecided. This prospective, randomized clinical trial aimed to compare clinical results of bone-patellar tendon-bone (BPTB) grafts and four-strand semitendinosus-gracilis (QHT) grafts for ACL reconstruction over a 1-year follow-up interval in Indian population.
METHODS: 42 consecutive patients with ACL injury were recruited, by pick and draw method and allotted into two groups with 21 patients in each group. Group A patients underwent arthroscopic ACL reconstruction using BPTB graft while QHT autograft was used for patients in Group B. All the patients underwent standard ipsilateral arthroscopic ACL reconstruction procedure using a single incision, antero-medial (AM) portal technique for BPTB or the QHT autograft by a same surgeon. Patients were followed up regularly for a minimum period of 1 year.
RESULTS: After one year, the Cincinnati score was 91 ± 4.117 in BPTB group and 89.29 ± 5.371 in QHT group (P = 0.282). There was no significant difference between the two groups in the mean scores with respect to pain, overall activity level and running in the Cincinnati score. None of the patients complained of the knee giving way. Similarly, at 1 year, the Lysholm score was 92.84 ± 2.630 and 90.55 ± 2.395 in the two groups respectively (P = 0.842). There were no episodes of locking or instability and there was no significant difference in the mean Lysholm scores regarding pain and squatting.
CONCLUSION: There was no significant functional difference between the two grafts in terms of Lysholm and the Cincinnati score, anterior knee laxity and altered sensation over proximal leg. The patients with QHT groups performed better than BPTB functionally at 6 month so early return to sport is possible even with QHT autograft.

Entities:  

Keywords:  ACL injury; ACL reconstruction; Comparison; Control; Hamstring graft; Patellar tendon graft; Randomised

Year:  2018        PMID: 31061594      PMCID: PMC6494777          DOI: 10.1016/j.jcot.2018.04.018

Source DB:  PubMed          Journal:  J Clin Orthop Trauma        ISSN: 0976-5662


  23 in total

1.  Hamstrings vs. patella tendon for anterior cruciate ligament reconstruction: a randomised controlled trial.

Authors:  D J Beard; J L Anderson; S Davies; A J Price; C A Dodd
Journal:  Knee       Date:  2001-03       Impact factor: 2.199

2.  Muscle strength and function before and after anterior cruciate ligament reconstruction using semitendonosus and gracilis.

Authors:  S L Keays; J Bullock-Saxton; A C Keays; P Newcombe
Journal:  Knee       Date:  2001-10       Impact factor: 2.199

3.  A prospective randomized comparison of patellar tendon versus semitendinosus and gracilis tendon autografts for anterior cruciate ligament reconstruction.

Authors:  Mark D Shaieb; Darryl M Kan; Spencer K Chang; Jay M Marumoto; Allen B Richardson
Journal:  Am J Sports Med       Date:  2002 Mar-Apr       Impact factor: 6.202

4.  A prospective randomized study of patellar versus hamstring tendon autografts for anterior cruciate ligament reconstruction.

Authors:  Kim A Jansson; Eric Linko; Jerker Sandelin; Arsi Harilainen
Journal:  Am J Sports Med       Date:  2003 Jan-Feb       Impact factor: 6.202

5.  A randomized comparison of patellar tendon and hamstring tendon anterior cruciate ligament reconstruction.

Authors:  Julian A Feller; Kate E Webster
Journal:  Am J Sports Med       Date:  2003 Jul-Aug       Impact factor: 6.202

6.  Four-strand hamstring tendon autograft compared with patellar tendon-bone autograft for anterior cruciate ligament reconstruction. A randomized study with two-year follow-up.

Authors:  A K Aune; I Holm; M A Risberg; H K Jensen; H Steen
Journal:  Am J Sports Med       Date:  2001 Nov-Dec       Impact factor: 6.202

7.  A comparison of quadruple semitendinosus and patellar tendon grafts in reconstruction of the anterior cruciate ligament.

Authors:  K Eriksson; P Anderberg; P Hamberg; A C Löfgren; M Bredenberg; I Westman; T Wredmark
Journal:  J Bone Joint Surg Br       Date:  2001-04

8.  Patellar tendon or semitendinosus tendon autografts for anterior cruciate ligament reconstruction? A prospective randomized study with a two-year follow-up.

Authors:  Lars Ejerhed; Jüri Kartus; Ninni Sernert; Kristina Köhler; Jon Karlsson
Journal:  Am J Sports Med       Date:  2003 Jan-Feb       Impact factor: 6.202

9.  Arthroscopic anterior cruciate ligament reconstruction: a metaanalysis comparing patellar tendon and hamstring tendon autografts.

Authors:  Kevin B Freedman; Michael J D'Amato; David D Nedeff; Ari Kaz; Bernard R Bach
Journal:  Am J Sports Med       Date:  2003 Jan-Feb       Impact factor: 6.202

10.  Anterior cruciate ligament replacement: comparison of bone-patellar tendon-bone grafts with two-strand hamstring grafts. A prospective, randomized study.

Authors:  Bruce D Beynnon; Robert J Johnson; Braden C Fleming; Pekka Kannus; Michael Kaplan; John Samani; Per Renström
Journal:  J Bone Joint Surg Am       Date:  2002-09       Impact factor: 5.284

View more
  2 in total

1.  Canine ACL reconstruction with an injectable hydroxyapatite/collagen paste for accelerated healing of tendon-bone interface.

Authors:  Qingsong Jiang; Liren Wang; Zhanhong Liu; Jinlei Su; Yajun Tang; Peijie Tan; Xiangdong Zhu; Kai Zhang; Xing Ma; Jia Jiang; Jinzhong Zhao; Hai Lin; Xingdong Zhang
Journal:  Bioact Mater       Date:  2022-05-17

2.  Return to Baseline Physical Activity After Bone-Patellar Tendon-Bone Versus Hamstring Tendon Autografts for Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Authors:  Jeremy J Bergeron; Quentin P Sercia; Justin Drager; Stéphane Pelet; Etienne L Belzile
Journal:  Am J Sports Med       Date:  2021-07-26       Impact factor: 7.010

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.